Noveome Biotherapeutics Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2000
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

State Ranking

Estimated Revenue & Financials

  • Noveome Biotherapeutics's estimated annual revenue is currently $5.7M per year.
  • Noveome Biotherapeutics's estimated revenue per employee is $155,000

Employee Data

  • Noveome Biotherapeutics has 37 Employees.
  • Noveome Biotherapeutics grew their employee count by 6% last year.
  • Noveome Biotherapeutics currently has 1 job openings.

Executive Contacts

NameTitle
Ashley EllisQuality Control Manager
Chad GlydeDirector Of Quality
Gretchen KraemerExecutive Administrator And Office Manager
WILLIAM GOLDENFounder, Chairman & CEO
RANDALL RUPPEVP Manufacturing & Development
LARRY BROWNEVP R&D/Chief Scientific Officer
Rachael BorromeoRegulatory Affairs Manager
Tyler OkelManager Of Biological Manufacturing Operations
Rick BanasDirector of Cell Therapy and Research at Noveome Biotherapeutics, Inc.
Stephen RaatAssociate Director of QA

Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome?s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.

keywords:N/A

37

Number of Employees

$5.7M

Revenue (est)

1

Current Jobs

6%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Rockland Immuno...
$14.1M9112%N/A
Braeburn
$9.6M62-29%N/A
Passage Bio
$5M32N/AN/A
DrugScan
$22.3M144-5%N/A
TechData Servic...
$11.2M72-1%N/A
Spark Therapeut...
$69.1M44620%N/A
BioTelemetry
$377.3M9762%N/A
Strongbridge Bi...
$13.5M87-24%N/A
WuXi Advanced T...
$47M3037%N/A
Noveome Biother...
$5.7M376%N/A

Noveome Biotherapeutics News

09/03/2019 - Noveome Biotherapeutics, Inc. Announces Passing of Board ...

PITTSBURGH--(BUSINESS WIRE)-- Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing ...

06/13/2019 - CORRECTING and REPLACING Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial Evaluating Topical Ocular Delivery of ST266 For the Treatment of

CORRECTING and REPLACING Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial ...

04/09/2019 - Noveome Biotherapeutics, Inc. Completes $15 Million Series ...

PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing ...